Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Perioperative IMFINZI® (durvalumab) plus neoadjuvant enfortumab vedotin reduced risk of recurrence by 49% and risk of death by 42% in muscle-invasive bladder cancer
-
Non-Invasive Flow Measurement Technology: Optimizing Complex Process Infrastructure via the DT-TDS 200 Series Ultrasonic Flow Meters from Drive Test GmbH
-
In HelloNation, Insurance Expert Devery Prince Breaks Down Affordable Insurance in Alaska
-
Melbourne coach Dominik Kulewski's Weight Loss Lab clients have now lost about 3 tonnes combined
-
Melbourne coach Dominik Kulewski's Weight Loss Lab clients have now lost about 3 tonnes combined
-
Widgets & Web Launches AI-Operated Investor Relations Websites for Public Companies at a Fixed $299 per Month
-
Widgets & Web Launches AI-Operated Investor Relations Websites for Public Companies at a Fixed $299 per Month
-
New Cryptocurrency Reality Check: Study Finds 79% of Pump.fun Tokens Go Quiet After Day One as Remittix Plans a 20% Supply Cut
-
XRP Price Prediction: Ledger Fix Slips Into November as Remittix’s 41-Currency PayFi Plan Adds a New Catalyst
-
Websouls Expands Globally with a Suite of In-House AI and Technology Products Technology
-
Swanson Vitamins Launches Swanson Vitamins Nexus Pro to Champion Registered Dietitians and Licensed Nutritionists at Every Stage of Their Careers
-
TJ Avazona's Founders in Focus Vol. 3 Reaches #1 in Three Amazon Categories
-
Thousands of Ontarians to Attend ‘Together for Publicly Funded Education’ Rallies
-
The Secret to Getting on a New York Wine List? Four Master Sommeliers Come Face to Face with Leading Italian Producers
-
2026 National Poppy Campaign launches with a donation “first” … and stunning mural: Don’t forget to Remember
-
The Ultimate Send-off to Summer: CSTS Debuts Global Entertainment IP PremierX at New York's Pier 17, Ushering in a New Era of Live Entertainment
-
Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer
-
Quanta Presents Positive Clinical Combination Data in KRAS G12D-Mutant CRC at ESMO and Highlights Pan-KRAS Progress
-
Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors
-
Solana Price Prediction: Solana Ventures Leads Hylo’s $1M Round as Remittix Earn Readies Aave, Morpho and Maple Finance Pools
-
Dogecoin Price Prediction: Grayscale Expands In-Kind Access as Remittix Earn Readies Aave, Morpho and Maple Finance Pools
-
DEEP Robotics Unveils Five Research Advances in Embodied AI
-
Management Executes Third Open Market Share Purchase as SNRY Transition Wraps Up and Company Targets $100M+ Synergistic Powerhouse
-
Tron Price Prediction: TRON Fee Revenue Beats ETH and SOL Combined as Remittix Plans 41 More Fiat Currencies
-
JST Buyback & Burn Upgrade: GasFree Revenue and $20.34M Surplus Injected as JUST's Ecosystem Trio Solidifies JST Token Value
-
JST Buyback & Burn Upgrade: GasFree Revenue and $20.34M Surplus Injected as JUST's Ecosystem Trio Solidifies JST Token Value
-
Crypto News: Hyperliquid Pushes for SEC Rule Changes as Remittix Agrees to Burn 20% of Total Supply
-
Best Crypto to Buy in October 2026? Swiss Retail Bitcoin ETF Gets Green Light as Remittix Plans a 64.3% Presale Price Rise
-
ML-Detect.com Highlights Its Commitment to Transparency in Digital Asset Recovery
-
Eurotrace Expands Its Blockchain Tracing and Digital Asset Investigation Services
-
Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026
-
ESMO 2026: NUBEQA® (darolutamide) Plus ADT and Radiation Therapy Reduces Risk of Metastasis or Death by 58% in Prostate Cancer Patients at High Risk of Recurrence
-
Dust-A-Side Turns Old Haul Road Material Into New Mine Roads
-
Taiwan Brings Herbal Heritage and Modern Innovation to SupplySide Global 2026
-
Cryptocurrency News: Reported Drift Hack Transfers Hit $61.56M as Remittix Earn Readies Morpho, Fluid and Maple Finance Pools
-
Likang Life Sciences Showcases Personalized Cancer Immunotherapy and Global Ambitions at Abu Dhabi Future Health Summit 2026
-
HBAR Price Prediction: Can Hedera Reclaim $0.10 as Remittix Plans to Remove 300M RTX From Supply?
-
Crypto Overview: Bitcoin Braces for October 30 Options Expiry as Remittix Plans a 64.3% Presale Price Increase
-
Rich DiGiovanna, Realtor in Woodbridge, VA, Marks 39 Years and 2,000 Families Moved Across Northern Virginia
-
Silverstein Interior Styling Continues Personalized, Style-Forward Home Design Approach for 2026/2027 in South Florida
-
Judges Under Fire Expands Digital Access Through Fall 2026 Documentary Campaign
-
Dogecoin Price Prediction: Dogecoin Labs Unites Teams Behind 500,000-User Wallet as Remittix Earn Targets Up to 22% APY
-
Best Crypto to Buy in October 2026? Tesla and SpaceX Hold 30,221 BTC as Remittix Plans to Cut Supply 20%
-
Bio-Thera Announces Promising Clinical Data for BAT8008 in Combination with BAT1308 in First-Line Non-Small Cell Lung Cancer at ESMO 2026
-
Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
-
NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma
-
Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
-
Binance Coin Price Today: BNB Near $744 as Binance.US Eyes Prediction Markets and Remittix Plans 41 More Fiat Currencies
-
Chainlink Price Prediction: LINK Near $12.16 After OpenZeppelin Deal as Remittix Earn Readies Morpho, Fluid and Maple Finance Pools
-
Asyad Group to Host Muscat Maritime Resilience Forum to Strengthen Global Trade Networks
